Cell therapy · clinical evidence
ACTL — Understand the evidence before considering treatment
ACTL requires a clearly identified technical definition and preparation protocol. It should not automatically be equated with CAR-T, TCR-T or other adoptive cell therapies.
What is the evidence?
Review the original protocol, mechanism, publication and regulatory or study status before interpreting effectiveness claims.
Safety and limitations
Manufacturing, infusion and immune-related risks require protocol-specific explanations and clinical supervision.
What should be assessed?
The cancer type, prior treatment, available research evidence and individual medical condition.